A detailed history of Asset Management One Co., Ltd. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 398,958 shares of TEVA stock, worth $6.98 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
398,958
Previous 401,279 0.58%
Holding current value
$6.98 Million
Previous $6.52 Million 10.26%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$15.81 - $18.96 $36,695 - $44,006
-2,321 Reduced 0.58%
398,958 $7.19 Million
Q2 2024

Jul 18, 2024

SELL
$12.78 - $17.4 $241,669 - $329,034
-18,910 Reduced 4.5%
401,279 $6.52 Million
Q1 2024

May 02, 2024

SELL
$10.67 - $14.43 $346,582 - $468,715
-32,482 Reduced 7.18%
420,189 $5.93 Million
Q4 2023

Jan 24, 2024

SELL
$8.12 - $10.63 $1.6 Million - $2.1 Million
-197,480 Reduced 30.37%
452,671 $4.73 Million
Q3 2023

Oct 19, 2023

BUY
$7.48 - $10.7 $257,274 - $368,026
34,395 Added 5.59%
650,151 $6.63 Million
Q2 2023

Jul 31, 2023

SELL
$7.2 - $9.47 $114,631 - $150,771
-15,921 Reduced 2.52%
615,756 $4.64 Million
Q1 2023

Apr 25, 2023

BUY
$8.36 - $11.37 $85,823 - $116,724
10,266 Added 1.65%
631,677 $5.59 Million
Q4 2022

Feb 06, 2023

BUY
$7.95 - $9.48 $6,924 - $8,257
871 Added 0.14%
621,411 $5.67 Million
Q3 2022

Nov 04, 2022

BUY
$6.86 - $11.95 $475,576 - $828,445
69,326 Added 12.58%
620,540 $5.01 Million
Q2 2022

Jul 29, 2022

SELL
$7.38 - $10.4 $50,228 - $70,782
-6,806 Reduced 1.22%
551,214 $4.15 Million
Q1 2022

May 13, 2022

SELL
$7.33 - $9.39 $150,096 - $192,279
-20,477 Reduced 3.54%
558,020 $5.24 Million
Q4 2021

Feb 09, 2022

SELL
$7.9 - $10.19 $37,627 - $48,534
-4,763 Reduced 0.82%
578,497 $4.87 Million
Q3 2021

Nov 02, 2021

SELL
$8.38 - $10.18 $105,202 - $127,799
-12,554 Reduced 2.11%
583,260 $5.68 Million
Q2 2021

Aug 03, 2021

BUY
$9.9 - $11.56 $127,264 - $148,603
12,855 Added 2.21%
595,814 $5.9 Million
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $264,600 - $327,807
-25,590 Reduced 4.21%
582,959 $6.73 Million
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $128,478 - $164,738
-14,922 Reduced 2.39%
608,549 $5.81 Million
Q3 2020

Nov 13, 2020

BUY
$8.57 - $12.69 $698,857 - $1.03 Million
81,547 Added 15.05%
623,471 $5.62 Million
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $8,014 - $12,949
-987 Reduced 0.18%
541,924 $6.68 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $5,719 - $11,499
855 Added 0.16%
542,911 $4.88 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $15,169 - $24,902
-2,323 Reduced 0.43%
542,056 $5.31 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $9,092 - $14,169
-1,476 Reduced 0.27%
544,379 $3.75 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $762,346 - $1.48 Million
93,885 Added 20.77%
545,855 $5.04 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $17 Million - $21.8 Million
-1,091,311 Reduced 70.71%
451,970 $7.09 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $51,502 - $84,155
3,530 Added 0.23%
1,543,281 $23.8 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $1.34 Million - $1.63 Million
63,537 Added 4.3%
1,539,751 $33.1 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $2.15 Million - $3.16 Million
128,011 Added 9.49%
1,476,214 $35.9 Million
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $751,200 - $993,944
45,036 Added 3.46%
1,348,203 $23 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $786,919 - $1.34 Million
-70,073 Reduced 5.1%
1,303,167 $24.7 Million
Q3 2017

Nov 14, 2017

SELL
$15.41 - $32.17 $436,873 - $912,019
-28,350 Reduced 2.02%
1,373,240 $24.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,401,590
1,401,590 $46.5 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.